Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5824825 | Clinical Therapeutics | 2015 | 11 Pages |
Abstract
There is currently little evidence to support the use of sildenafil in term or near-term infants with persistent pulmonary hypertension of the newborn in areas in which inhaled nitric oxide is available. More data are needed to determine the effectiveness and dosing of sildenafil in improving outcomes for term and premature infants. Sildenafil dosing and safety studies are needed, especially among premature infants, before efficacy trials are performed.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Krystle M. MD, Matthew MD, MPH,